Correlation Between Sichuan Hebang and Innovative Medical

Can any of the company-specific risk be diversified away by investing in both Sichuan Hebang and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sichuan Hebang and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sichuan Hebang Biotechnology and Innovative Medical Management, you can compare the effects of market volatilities on Sichuan Hebang and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sichuan Hebang with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sichuan Hebang and Innovative Medical.

Diversification Opportunities for Sichuan Hebang and Innovative Medical

0.87

Correlation Coefficient

Sichuan Hebang  Innovative Medical

Very poor diversification

The 3 months correlation between Sichuan and Innovative is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Sichuan Hebang Biotechnology and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Sichuan Hebang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sichuan Hebang Biotechnology are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Sichuan Hebang i.e., Sichuan Hebang and Innovative Medical go up and down completely randomly.

Pair Corralation between Sichuan Hebang and Innovative Medical

Assuming the 90 days trading horizon Sichuan Hebang Biotechnology is expected to generate 0.5 times more return on investment than Innovative Medical. However, Sichuan Hebang Biotechnology is 2.02 times less risky than Innovative Medical. It trades about 0.1 of its potential returns per unit of risk. Innovative Medical Management is currently generating about -0.03 per unit of risk. If you would invest  205.00  in Sichuan Hebang Biotechnology on September 5, 2024 and sell it today you would earn a total of  9.00  from holding Sichuan Hebang Biotechnology or generate 4.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Sichuan Hebang Biotechnology  vs.  Innovative Medical Management

Sichuan Hebang Biote

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sichuan Hebang Biotechnology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sichuan Hebang sustained solid returns over the last few months and may actually be approaching a breakup point.

Innovative Medical

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sichuan Hebang and Innovative Medical

The main advantage of trading using opposite Sichuan Hebang and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sichuan Hebang position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.

The idea behind Sichuan Hebang Biotechnology and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.